ES2104507A1 - Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros. - Google Patents

Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros.

Info

Publication number
ES2104507A1
ES2104507A1 ES09500449A ES9500449A ES2104507A1 ES 2104507 A1 ES2104507 A1 ES 2104507A1 ES 09500449 A ES09500449 A ES 09500449A ES 9500449 A ES9500449 A ES 9500449A ES 2104507 A1 ES2104507 A1 ES 2104507A1
Authority
ES
Spain
Prior art keywords
dogs
prepare
pharmaceutical composition
composition intended
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09500449A
Other languages
English (en)
Other versions
ES2104507B1 (es
Inventor
Garcia Pilar Quijano
Banos Jaime Melendo
Quilez Purificacion Benavent
Gil Gabriel Espelleta
Riuro Ferran Junca
Riuro Miquel Junca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Masterfarm SL
Original Assignee
Masterfarm SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masterfarm SL filed Critical Masterfarm SL
Priority to ES9500449A priority Critical patent/ES2104507B1/es
Publication of ES2104507A1 publication Critical patent/ES2104507A1/es
Application granted granted Critical
Publication of ES2104507B1 publication Critical patent/ES2104507B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EMPLEO DE HIDROLIZADO DE GELATINA PARA PREPARAR UNA COMPOSICION FARMACEUTICA DESTINADA A LA PREVENCION Y TRATAMIENTO DE LA DISPLASIA DE CADERA EN PERROS. LA PRESENTE INVENCION SE REFIERE AL EMPLEO DE UN HIDROLIZADO DE GELATINA ALTAMENTE PURIFICADO PARA PREPARAR UNA COMPOSICION FARMACEUTICA DESTINADA A SER ADMINISTRADA A PERROS DE CORTA EDAD, PRINCIPALMENTE PERROS DE AQUELLAS ESPECIES CON MAYOR PREDISPOSICION A DESARROLLAR DISPLASIA DE CADERA, TAL COMO OCURRE CON EL PASTOR ALEMAN, ROTTWEILER, MASTIN, ENTRE OTRAS, CON EL FIN DE PREVENIRLA, ASI COMO A PERROS ADULTOS EN LOS PRIMEROS ESTADIOS DE LA ENFERMEDAD Y, TAMBIEN A AQUELLOS QUE YA SE ENCUENTRAN EN LA FASE INFLAMATORIA DE DICHA ENFERMEDAD.
ES9500449A 1995-03-07 1995-03-07 Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros. Expired - Fee Related ES2104507B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9500449A ES2104507B1 (es) 1995-03-07 1995-03-07 Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9500449A ES2104507B1 (es) 1995-03-07 1995-03-07 Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros.

Publications (2)

Publication Number Publication Date
ES2104507A1 true ES2104507A1 (es) 1997-10-01
ES2104507B1 ES2104507B1 (es) 1998-07-01

Family

ID=8289693

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9500449A Expired - Fee Related ES2104507B1 (es) 1995-03-07 1995-03-07 Empleo de hidrolizado de gelatina para preparar una composicion farmaceutica destinada a la prevencion y tratamiento de la displasia de cadera en perros.

Country Status (1)

Country Link
ES (1) ES2104507B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048516A1 (es) * 1998-03-25 1999-09-30 Masterfarm, S.L. Uso de hidrolizados de gelatina

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772476A (en) * 1986-03-12 1988-09-20 Ralston Purina Company Method for reducing the severity of hip joint laxity in dogs
US4866082A (en) * 1988-04-06 1989-09-12 American Home Products Corporation Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772476A (en) * 1986-03-12 1988-09-20 Ralston Purina Company Method for reducing the severity of hip joint laxity in dogs
US4866082A (en) * 1988-04-06 1989-09-12 American Home Products Corporation Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048516A1 (es) * 1998-03-25 1999-09-30 Masterfarm, S.L. Uso de hidrolizados de gelatina

Also Published As

Publication number Publication date
ES2104507B1 (es) 1998-07-01

Similar Documents

Publication Publication Date Title
BR0008059A (pt) Composições de valdecoxib
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
BG101118A (en) Therapeutical compounds
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
PT782449E (pt) Processo de fabrico de unidades de dosagem por granulacao humida
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
DE122010000050I1 (de) Sublinguales oder bukkales arzneimittel
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
BG106030A (en) Pharmaceutical composition
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE69833377D1 (de) Pharmazeutische zusammensetzungen enthaltend lysostaphin allein oder in kombination mit einem antibiotikum zur behandlung von staphylokokkeninfektionen
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
ATE165514T1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
FR2705673B1 (fr) Compositions comportant des dérivés d'acides aminés, leurs procédés de préparation et leurs utilisations.
ATE249835T1 (de) Immunoregulator
WO1996022305A3 (en) Modified peptides
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
BG103512A (en) Substituted pyramidine compounds and their application
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971001

Kind code of ref document: A1

Effective date: 19971001

FD2A Announcement of lapse in spain

Effective date: 20150826